Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128496) titled 'Clinical study on predicting the response of lung cancer immunotherapy through drug testing by integrating quantitative systems pharmacology and twin technology' on July 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Sun Yat-sen University Cancer Center
Condition:
advanced lung cancer trial subjects /patients
Intervention:
Safety indicators:None
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-08-01
Target Sample Size: Safety indicators:300;QSP - Digital Twin Model Virtual Patient Group:300;
Countries of Recruitment:
China
To know more, vi...